Abstract:NF-κB transcription factors critically regulate the expression of genes which are involved in important cellular processes, including cellular proliferation and apoptosis. Abnormal activation of the NF-κB signaling pathway has been implicated in a variety of human cancers. Hyper-activation of the NF-κB signaling pathway has been found to lead to tumor survival, anti-apoptosis and invasion in the development of prostate cancer. In the present work, we identified Lycorine as a potent NF-κB inhibitor using a NF-κB activity dependent luciferase reporter in PC3 and DU145 prostate cancer cells. With this reporter gene assay, we found that Lycorine significantly suppressed the constitutive NF-κB activity as well as the NF-κB activity induced by TNF-α, LPS, PMA and IL-1β. Western blotting analysis of the NF-κB signaling pathway further showed that Lycorine inhibited IκB-α (inhibitor of κB) phosphorylation, IκB-α degradation, and p65 phosphorylation. Consistent with this, the subsequent nuclear translocation of p65 was blocked by Lycorine as evidenced in the immunofluorescence assay and western blotting. Furthermore, we observed that cell cycle was arrested at G2/M in Lycorine treated cells using FACS analysis. Western blotting analysis indicated that Lycorine increased the expression of Cyclin D1 but decreased the expression of p21. In addition, FACS analysis showed that Lycorine induced apoptosis in DU145 and PC3 cells. Western blotting analysis revealed that Lycorine decreased the expression of anti-apoptosis genes myc, survivin and Bcl-2 while increased cleavage of PARP. Finally, we observed a significant anticancer effect of Lycorine in a RM-1 prostate cancer xenograft mouse model. In agreement with its in vitro anticancer effect, Lycorine inhibited p65 phosphorylation, IKK-β phosphorylation and the expression of Ki-67, while increased the cleavage of Caspase 3 in tumor tissue. Taken together, our data demonstrated the in vitro and in vivo anti-prostate cancer activity of Lycorine by inhibiting the NF-κB signaling pathway, and highlighted it as a lead compound for further development into an effective anticancer drug.

Eriocalyxin B Blocks Human SW1116 Colon Cancer Cell Proliferation, Migration, Invasion, Cell Cycle Progression and Angiogenesis Via the JAK2/STAT3 Signaling Pathway.

Diterpenoid C of Radix Curcumae: an Inhibitor of Proliferation and Inducer of Apoptosis in Human Colon Adenocarcinoma Cells Acting Via Inhibiting MAPK Signaling Pathway

Erianin Induces Apoptosis Of Colorectal Cancer Cells Via Activation Of Jnk Signaling Pathways

Erianin Impedes the Proliferation and Metastatic Migration Through Suppression of STAT-3 Phosphorylation in Human Esophageal Cancer Cells

Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.

Eupalinolide J Induces Apoptosis, Cell Cycle Arrest, Mitochondrial Membrane Potential Disruption and DNA Damage in Human Prostate Cancer Cells.

Β,β-Dimethylacrylshikonin Induces Mitochondria Dependent Apoptosis Through ERK Pathway in Human Gastric Cancer SGC-7901 Cells.

Eriocalyxin B ameliorated Crohn's disease-like colitis by restricting M1 macrophage polarization through JAK2/STAT1 signalling

Natural Diterpenoid Eriocalyxin B Covalently Modifies Glutathione and Selectively Inhibits Thioredoxin Reductase Inducing Potent Oxidative Stress-Mediated Apoptosis in Colorectal Carcinoma RKO Cells.

Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells Via Targeting STAT3 Signaling Pathway

Erianin suppresses proliferation and migration of cancer cells in a pyruvate carboxylase-dependent manner

17-Hydroxy-Jolkinolide B Inhibits Signal Transducers And Activators Of Transcription 3 Signaling By Covalently Cross-Linking Janus Kinases And Induces Apoptosis Of Human Cancer Cells

Eupalinolide J Inhibits Cancer Metastasis by Promoting STAT3 Ubiquitin-Dependent Degradation

Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF- κ B and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner

Erianin Inhibits Indoleamine 2, 3-Dioxygenase - Induced Tumor Angiogenesis

In vitro and in vivo anticancer activity of Lycorine in prostate cancer by inhibiting NF-κB signaling pathway

The Effect and Mechanism of Erianin on the Reversal of Oxaliplatin Resistance in Human Colon Cancer Cells.

Design, synthesis, and discovery of Eudistomin Y derivatives as lysosome-targeted antiproliferation agents

Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway

Eriodictyol Inhibits Proliferation, Metastasis and Induces Apoptosis of Glioma Cells via PI3K/Akt/NF-κB Signaling Pathway

Research and development of erythroblastine A as a STAT3 inhibitor of lead compound and its application in tumor therapy